Tvardi Therapeutics(CH:TVRD)
CH:TVRD
Tvardi Therapeutics earnings date
Tvardi Therapeutics (TVRD) Q2 2025 Earnings Report
2 Followers
CH:TVRD Q2 2025 EPS Results
- Actual EPS
- -CHF 0.84
- Consensus EPS
- -CHF 0.57
- Beat/Miss
- Missed by -CHF 0.27
- One Year Ago EPS
- -CHF 11.05
CH:TVRD Q2 2025 Revenue Results
- Actual Revenue
- CHF 0
- Expected Revenue
- CHF 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/14/2025
- Time
- After Close
- Conference Call
- Thursday, August 14, 2025
CH:TVRD Upcoming Earnings
Tvardi Therapeutics's next earnings date is estimated for April 6, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:TVRD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 06, 2027 | 2026 (Q4) | -0.39- | -0.61 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -0.48-0.40 | -0.5 | 18.64% (+0.09) | |
| Aug 14, 2026 | 2026 (Q2) | -0.59-0.58 | -0.84 | 31.00% (+0.26) | |
| May 08, 2026 | 2026 (Q1) | ―- | -2.7 | ― | |
| Mar 31, 2026 | 2025 (Q4) | -0.62-0.61 | -2.7 | 77.33% (+2.09) | |
| Nov 13, 2025 | 2025 (Q3) | -0.84-0.50 | -6.87 | 92.80% (+6.38) | |
| Aug 14, 2025 | 2025 (Q2) | -0.57-0.84 | -11.05 | 92.41% (+10.21) | |
| May 13, 2025 | 2025 (Q1) | -0.49-2.70 | -16.92 | 84.03% (+14.21) | |
| Feb 26, 2025 | 2024 (Q4) | ―-1.41 | -5.94 | 76.27% (+4.53) | |
| Nov 04, 2024 | 2024 (Q3) | -0.20-0.19 | -0.44 | 56.15% (+0.25) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

